Research highlights the benefits of a comprehensive strategy, involving nutritional optimization, psychological assessment, and addressing septic complications before surgery. Despite many CD patients being on immune-suppressing medications, studies indicate that most of these medications are safe to use and should not delay surgery. However, a personalized approach for each case is needed. This review underscores the importance of multi-disciplinary team led peri-operative management of CD patients. We suggest that this can be done at a dedicated perioperative clinic for prehabilitation, with the potential to enhance outcomes for CD patients undergoing surgery.
Keyphrases
- minimally invasive
- patients undergoing
- newly diagnosed
- ejection fraction
- coronary artery bypass
- prognostic factors
- type diabetes
- acute kidney injury
- palliative care
- risk factors
- adipose tissue
- coronary artery disease
- skeletal muscle
- risk assessment
- nk cells
- surgical site infection
- insulin resistance
- quality improvement
- weight loss
- case control